Published in Br Heart J on December 01, 1978
Haemodynamic changes induced by prostacyclin in man. Br Heart J (1980) 1.11
Molecular mechanisms of pulmonary arterial remodeling. Mol Med (2014) 1.05
Prostaglandin E1 therapy for digital ulcers in scleroderma. Can Med Assoc J (1982) 1.00
Cervical spondylotic amyotrophy. Eur Spine J (2010) 0.99
Comparison between prostaglandin E1 and epoprostenol (prostacyclin) in infants after heart surgery. Br Heart J (1991) 0.92
Haemodynamic effects of prostacyclin (PGI2) in pulmonary hypertension. Br Heart J (1981) 0.89
Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension. Br Heart J (1983) 0.84
Effect of prostaglandin E1 on pulmonary circulation in pulmonary atresia. A quantitative morphometric study. Br Heart J (1980) 0.83
New approaches to the treatment of pulmonary hypertension: from bench to bedside. Cardiol Rev (2010) 0.80
Reactive pulmonary hypertension after a switch operation. Successful treatment with glyceryl trinitrate. Br Heart J (1985) 0.76
Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma. Br Heart J (1982) 0.75
Observations on the effects of infusion of prostaglandin E in man. Acta Physiol Scand (1959) 2.21
Assessment of cardiac contractility. The relation between the rate of pressure rise and ventricular pressure during isovolumic systole. Circulation (1971) 2.15
Cardiovascular and metabolic response to infusions of prostaglandin E1 and to simultaneous infusions of noradrenaline and prostaglandin E1 in man. Prostaglandin and related factors 35. Acta Physiol Scand (1965) 1.52
Some regulatory mechanisms of the human pulmonary vascular bed. Circulation (1962) 1.19
Circulatory and respiratory effects of different doses of prostaglandin E1 in man. Acta Physiol Scand (1969) 1.18
Mechanisms underlying vasomotor regulation of regional pulmonary blood flow in normal and disease states. Am J Med (1974) 1.04
Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels. J Pharmacol Exp Ther (1975) 1.02
Quantitative radiocardiography. I. Theoretical considerations. Circulation (1962) 0.98
The active responses of pulmonary veins in intact dogs to prostaglandins F2 alpha and E1. J Pharmacol Exp Ther (1969) 0.93
Effects of prostaglandin E1 and adrenaline on the pulmonary vascular resistance (PVR) in isolated rabbit lungs. Life Sci (1967) 0.92
Effects of isoproterenol on the pulmonary blood volume in patients with valvular heart disease and primary myocardial disease. Circulation (1968) 0.92
Actions of prostaglandins E1 and F2alpha on isolated intrapulmonary vascular smooth muscle. Proc Soc Exp Biol Med (1975) 0.90
Cardiovascular actions of prostaglandins E1 and F2 alpha in the cat. Eur J Pharmacol (1973) 0.88
Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Heart (2007) 1.85
Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol (1999) 1.65
Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet (1979) 1.57
Humoral immunosuppression in men exposed to polycyclic aromatic hydrocarbons and related carcinogens in polluted environments. Environ Health Perspect (1994) 1.49
Haemodynamic changes induced by prostacyclin in man. Br Heart J (1980) 1.11
Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs. Gastroenterology (1975) 1.03
Prostacyclin for pulmonary hypertension. Lancet (1980) 0.98
Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Heart (2000) 0.96
Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (2000) 0.92
Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment. Arch Intern Med (2001) 0.89
Increased plasma catecholamines in patients with Friedreich's ataxia. Can J Neurol Sci (1982) 0.85
Verapamil normalizes the response of left ventricular early diastolic filling to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (1997) 0.85
Impaired response of the forearm resistance but not conductance vessels to reactive hyperemia in hypertrophic cardiomyopathy. Angiology (1999) 0.84
Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol (1986) 0.84
Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy. Heart Vessels (1996) 0.84
Prostacyclin for acute coronary insufficiency. Artery (1980) 0.83
Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy. Heart (2005) 0.82
Effect of somatostatin analogs on gastric and pancreatic secretion. Proc Soc Exp Biol Med (1977) 0.82
Determinants of depressed left ventricular ejection fraction in pure mitral stenosis with preserved sinus rhythm. J Heart Valve Dis (1996) 0.81
Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy. Int J Cardiol (2004) 0.80
Prostacyclin, nitroglycerin, and effort angina. Lancet (1981) 0.79
Detection of benzo[a]pyrene-DNA adducts in leukocytes of coke oven workers. Pathol Biol (Paris) (2000) 0.79
[Therapy of polycythemia vera with busulfan (myleran). Report on results in 40 patients]. Folia Haematol Int Mag Klin Morphol Blutforsch (1970) 0.79
Biomarkers of carcinogenesis in humans exposed to polycyclic aromatic hydrocarbons. Mutat Res (1999) 0.79
Effects of acute euglycemic hyperinsulinemia on urinary nitrite/nitrate excretion and plasma endothelin-1 levels in men with essential hypertension and normotensive controls. Metabolism (1999) 0.78
Successful coronary stent implantation in a patient with primary antiphospholipid syndrome. Blood Coagul Fibrinolysis (1998) 0.78
Lack of beneficial effects of L-arginine infusion in primary pulmonary hypertension. Wien Klin Wochenschr (1994) 0.78
The effect of verapamil on response of coronary vasomotion to handgrip exercise in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (2001) 0.77
Intergenerational CAG repeat expansion at ERDA1 in a family with childhood-onset depression, schizoaffective disorder, and recurrent major depression. Am J Med Genet (1999) 0.77
Verapamil improves the response of coronary vasomotion to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (1999) 0.77
[Prognostic value of selected hemodynamic parameters featuring left ventricular systolic and diastolic function in patients with dilated cardiomyopathy]. Pol Arch Med Wewn (1992) 0.77
Effect of having a functioning cadaveric renal transplant on cardiovascular mortality risk in patients on renal replacement therapy. Nephrol Dial Transplant (1995) 0.77
[Pressure increases in the left ventricle and aorta during an involuntarily induced cough reflex]. Acta Physiol Pol (1973) 0.76
[Cytoimmunologic changes in material obtained from bronchoalveolar lavage (BAL) in asymptomatic individuals chronically exposed to silica dust]. Pneumonol Alergol Pol (2000) 0.76
Effect of 13-NLE-motilin on gastric secretion, serum gastrin level and mucosal blood flow in dogs. J Physiol (1977) 0.75
Impairment of coronary microvascular flow in hypertrophic cardiomyopathy. Eur Heart J (2002) 0.75
Prostacyclin in the therapy of peripheral arterial disease. Adv Prostaglandin Thromboxane Res (1980) 0.75
[The behaviour of haemodynamic indicators of pulmonary circulation and spirometric parametera under the influence of Sadamin in patients with chronic pulmonary heart syndrome]. Przegl Lek (1975) 0.75
[Distribution of blood pressure in male population aged 40--59 years (author's transl)]. Przegl Lek (1975) 0.75
Sodium tolerance test in the detection of early stages of heart failure. Pol Med J (1972) 0.75
The effects of regitine haemodynamics of pulmonary circulation in pulmonary hypertension in man. Acta Physiol Pol (1974) 0.75
[The hemodynamic picture of primary congestive myocardiopathy and the clinical course of the disease]. Pol Arch Med Wewn (1980) 0.75
[Ultrastructural changes in the deltoid muscle (m. deltoideus) in congestive cardiomyopathy]. Patol Pol (1980) 0.75
[Phonocardiographic picture and anatomical changes in persisting ductus arteriosus]. Pol Tyg Lek (1971) 0.75
[Results of streptokinase therapy in arterial obliterative diseases]. Kardiol Pol (1973) 0.75
[Relationship between auscultatory findings and hemodynamic changes in atrial septal defect of the ostium secundum type. I. Heart sounds]. Kardiol Pol (1974) 0.75
[Puerperal cardiomyopathy]. Pol Tyg Lek (1974) 0.75
[Prospective studies of the respiratory system in coke plant workers]. Folia Med Cracov (1992) 0.75
[Effect of prostaglandin E1 on the left ventricle function in patients with congestive heart failure in the course of mitral valvular defects (author's transl)]. Przegl Lek (1978) 0.75
[Hemodynamic studies in myocardial infarct]. Pol Tyg Lek (1972) 0.75
Treatment with prostacyclin of various forms of spontaneous angina pectoris not responding to placebo. Pharmacol Res Commun (1984) 0.75
[Incidence of coronary disease in patients at the Povincial Cardiologic Outpatient Clinic in Cracow]. Folia Med Cracov (1973) 0.75
[Lipoproteins (A) after a history of myocardial infarction, arteriosclerosis obliterans, hypertension and hyperlipidemia]. Kardiol Pol (1991) 0.75
[Polycardiographic evaluation of left ventricular contraction following glucagon administration to patients with chronic circulatory failure]. Pol Tyg Lek (1976) 0.75
[Myocardial blood flow in patients with mitral valve diseases]. Pol Arch Med Wewn (1974) 0.75
[Myocardial blood flow in primary congestive cardiomyopathy]. Pol Tyg Lek (1974) 0.75
[Usefulness of measuring central venous pressure for the evaluation of diastolic volume of right ventricle in patients with right ventricular failure]. Pol Arch Med Wewn (1971) 0.75
[Relationship between auscultatory findings and hemodynamic changes in atrial septal defect of the ostium secundum type. II. Intracardiac murmurs]. Kardiol Pol (1974) 0.75
[11-year survival in a case of ventricular septum rupture in myocardial infarct]. Kardiol Pol (1977) 0.75
[Epidemiology of pulmonary heart disease in patients at the medical departments of Cracow and Cracow Province]. Przegl Lek (1971) 0.75
[Effect of propranolol on the electrocardiogram in Wolff-Parkinson-White disease]. Pol Tyg Lek (1971) 0.75
[Ultrastructural studies of skeletal muscles in primary congestive heart failure]. Kardiol Pol (1980) 0.75
[Clinical evaluation of the potassium chloride and Gynergen tests for the differentiation of the changes of heart repolarization in the electrocardiogram]. Pol Arch Med Wewn (1969) 0.75
[Effect of a methylated derivative of prostaglandin E2 (16,16-dimethyl PGE2) on the human cardiovascular system]. Pol Arch Med Wewn (1982) 0.75
Comparison of results derived from follow-up examination of respiratory systems in chosen groups of metallurgists. Pol J Occup Med Environ Health (1992) 0.75
[Primary pulmonary hypertension. Study of hemodynamics and pulmonary ventilation disorders]. Pol Arch Med Wewn (1975) 0.75
[Clinical methods for the determination of the myocardial blood flow (author's transl)]. Przegl Lek (1973) 0.75
[Determination of myocardial blood flow in man using isotope Xenon-133]. Pol Arch Med Wewn (1972) 0.75
[Blood flow through the cardiac muscle and pulmonary circulation haemodynamics in patients with defects of the mitral orifice (author's transl)]. Przegl Lek (1975) 0.75
[Pulmonary hemodynamic changes following mitral commissurotomy in patients with pulmonary hypertension. Late results]. Kardiol Pol (1974) 0.75
[Sodium tolerance test in the detection of early stages of heart failure]. Pol Arch Med Wewn (1971) 0.75
[Puerperal cardiomyopathy--a report of 2 cases]. Pol Tyg Lek (1974) 0.75
[Patterns of muscle blood flow determined by means of 133 Xe in early stages of circulatory failure]. Pol Arch Med Wewn (1972) 0.75
[Left ventricular volume and mass in primary congestive cardiomyopathy]. Pol Arch Med Wewn (1977) 0.75
[The value of polycardiographic records in the evaluation of pulmonary artery blood pressure. Numerical characteristics of polycardiogram in pulmonary tension]. Pol Tyg Lek (1970) 0.75
Effect of prostaglandin E1 (PGE1) and indomethacin on pulmonary circulation in man. Acta Med Pol (1979) 0.75
[The effect of idiopathic thoracic scoliosis on the development of cor pulmonale]. Pol Tyg Lek (1970) 0.75
[Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)]. Przegl Lek (1980) 0.75
[Case of straight thoracic spine syndrome confirmed by hemodynamic studies]. Wiad Lek (1973) 0.75
[Effect of prostacycline on pulmonary circulation in pulmonary hypertension]. Kardiol Pol (1984) 0.75
[Exercise test in the diagnosis of asthma in epidemiological studies]. Pol Tyg Lek (1974) 0.75
[Electrocardiogram of patients with primary congestive cardiomyopathy. Own experience (author's transl)]. Przegl Lek (1980) 0.75
Haemodynamic and antihypertensive effect of prostacyclin. Adv Exp Med Biol (1984) 0.75
[Effect of intravenous propranolol on the electrocardiographic curve]. Pol Tyg Lek (1970) 0.75
[Hemodynamics of the right cardiac ventricle and pulmonary circulation and the functional state of the lungs in patients with chronic cor pulmonale syndrome]. Folia Med Cracov (1975) 0.75
[Selected clinical aspects of primary congestive cardiomyopathy basing on observation of 83 patients (author's transl)]. Przegl Lek (1981) 0.75
Hemodynamic effects of prostacyclin in man. Adv Prostaglandin Thromboxane Res (1980) 0.75
Prostacyclin for unstable angina. N Engl J Med (1980) 0.75
[Tetralogy of Fallot in mirror-image dextrocardia and total situs inversus]. Kardiol Pol (1981) 0.75
Plasma fibrinolytic activity in healthy subjects with high and low lipoprotein(a) concentrations. Thromb Res (1992) 0.75
Effect of haemodynamic disturbances on the functions of the liver in chronic circulatory failure. Acta Med Pol (1980) 0.75